Sai Life Sciences (NSE:SAILIFE, BOM:544306) has inaugurated Unit VI, a veterinary active pharmaceutical ingredient (API) manufacturing facility, at Bidar in Karnataka, India, according to a Thursday filing with the Indian bourses.
The unit is located adjacent to the company's flagship Unit IV site in Bidar and is intended to cater to global animal health companies, the company said in the filing.